Home » Newsletters » BioWorld Science

BioWorld Science

April 28, 1998

View Archived Issues

Company Profile: Cyclacel

FDA advisory committee will meet to discuss Avakine NDA

Company Profile: HemispheRx Biopharma

Fasudil hydrochloride inhibits HIV-1 replication in vitro

Dupuytren's disease treatment shows promise in early clinical trials

TAK-044 and its effects on liver injury and portal hypertension in rats

Icos: Q1 1998 highlights

Clinical trials of reformulated H-BIG completed

New findings support the hypothesis that fetal cells are involved in scleroderma

t-PA treatment may be beneficial to stroke patients and health care systems

Gastric prokinetic/antiemetic agents from Dainippon

Toagosei presents several related antitumor series

Telomerase-deficient mice have impaired tissue and organ function

Theratechnologies and Genetix enter strategic alliance

Glaxo Wellcome seeks approval for combination asthma product

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

Guilford: Q1 1998 highlights

Interim analysis of Betafectin supports continued clinical development

Hemosol's blood substitute to be assessed in U.K. trial

FDA advisory panel recommends approval of the Heart Laser System

Synthetic, nonandrogenic DHEA active in animal model of MS

Lilly presents naphthalene and related compounds for postmenopausal therapy

Anti-MRSA carbapenems developed at Suntory

Substance P antagonists from Pfizer especially useful for pain, inflammation

Takeda reveals novel inhibitors of Na+/H+ exchange

Ionotropic glutamate receptor ligands for neurological and CNS disorders

Orbofiban: a fibrinogen antagonist for the treatment of acute coronary syndromes

Phase I data reported for Vasoflux at ACC meeting in Rio

Astra's 3-HAO inhibitor NCR-631 demonstrates neuroprotective potential

Efficacy of StressGen's HspE7 in preclinical cancer models reported at FASEB 98

Merck presents clinical data on COX-2 inhibitor at FASEB 98

Activa Parkinson's Control therapy receives CE Mark approval; European introduction announced

Eletriptan for migraine during menstruation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...